Display Settings:

Format

Send to:

Choose Destination
    Cardiol Clin. 2010 Aug;28(3):497-516.

    Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.

    Source

    Providence Medical Research Center, Spokane, WA 99204, USA. sahas@uw.edu

    Abstract

    Diabetes mellitus leads to the development of a host of micro- and macrovascular complications, which collectively lead to substantial morbidity and mortality. Among the microvascular complications of diabetes, diabetic kidney disease is the most common. Macrovascular complications from diabetes lead to a 2- to 4-fold increase in the incidence of cardiovascular disease and up to twice the mortality from cardiovascular causes as compared with nondiabetic individuals. This article discusses the various drug classes used to treat diabetes mellitus, and reviews the current clinical evidence linking glycemic control using these drug classes on diabetic kidney and cardiovascular disease.

    2010 Elsevier Inc. All rights reserved.

    PMID:
    20621253
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk